1. Cost comparison of continued anticoagulation with rivaroxaban versus placebo based on the 1-year EINSTEIN-Extension trial efficacy and safety results. (3rd June 2018) Authors: Wells, Philip S.; Lensing, Anthonie W. A.; Haskell, Lloyd; Levitan, Bennett; Laliberté, François; Durkin, Michael; Ashton, Veronica; Xiao, Yongling; Crivera, Concetta; Lejeune, Dominique; Schein, Jeff; Lefebvre, Patrick Journal: Journal of medical economics Issue: Volume 21:Number 6(2018) Page Start: 587 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Risk of Severe Bleeding With Extended Rivaroxaban to Prevent Venous Thromboembolism in Acute Medically Ill Patients With Bronchiectasis. (October 2021) Authors: Lipardi, Concetta; Elliott, C. Gregory; Sugarmann, Chiara L.; Haskell, Lloyd; Spyropoulos, Alex C.; Raskob, Gary E.; Xu, Jianfeng; Lu, Wentao; Marsigliano, Jessica; Spiro, Theodore; Yuan, Zhong; Wu, Shujian; Barnathan, Elliot S. Journal: Clinical and applied thrombosis/hemostasis Issue: Volume 27(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization: Impact of Concomitant Clopidogrel on Efficacy and Safety. Issue 23 (8th December 2020) Authors: Hiatt, William R.; Bonaca, Marc P.; Patel, Manesh R.; Nehler, Mark R.; Debus, Eike Sebastian; Anand, Sonia S.; Capell, Warren H.; Brackin, Taylor; Jaeger, Nicole; Hess, Connie N.; Pap, Akos F.; Berkowitz, Scott D.; Muehlhofer, Eva; Haskell, Lloyd; Brasil, David; Madaric, Juraj; Sillesen, Henrik; ... Journal: Circulation Issue: Volume 142:Issue 23(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Rivaroxaban: a novel oral anticoagulant for the prevention and treatment of several thrombosis‐mediated conditions. (23rd May 2013) Authors: Sarich, Troy C.; Peters, Gary; Berkowitz, Scott D.; Misselwitz, Frank; Nessel, Christopher C.; Burton, Paul; Cook‐Bruns, Nancy; Lensing, Anthonie W.A.; Haskell, Lloyd; Perzborn, Elisabeth; Kubitza, Dagmar; Moore, Kenneth T.; Jalota, Sanjay; Weber, Juergen; Pan, Guohua; Sun, Xiang; Westermeier, To... Journal: Annals of the New York Academy of Sciences Issue: Volume 1291(2013) Page Start: 42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A Cross‐Study Analysis Evaluating the Effects of Food on the Pharmacokinetics of Rivaroxaban in Clinical Studies. (5th July 2017) Authors: Zhang, Liping; Peters, Gary; Haskell, Lloyd; Patel, Purve; Nandy, Partha; Moore, Kenneth Todd Journal: Journal of clinical pharmacology Issue: Volume 57:Number 12(2017) Page Start: 1607 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. An open‐label study to estimate the effect of steady‐state erythromycin on the pharmacokinetics, pharmacodynamics, and safety of a single dose of rivaroxaban in subjects with renal impairment and normal renal function. (3rd July 2014) Authors: Moore, Kenneth T.; Vaidyanathan, Seema; Natarajan, Jaya; Ariyawansa, Jay; Haskell, Lloyd; Turner, Kenneth C. Journal: Journal of clinical pharmacology Issue: Volume 54:Number 12(2014:Dec.) Page Start: 1407 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Length of stay and economic consequences with rivaroxaban vs enoxaparin/vitamin K antagonist in patients with DVT and PE: findings from the North American EINSTEIN clinical trial program. (October 2014) Authors: Bookhart, Brahim K.; Haskell, Lloyd; Bamber, Luke; Wang, Maria; Schein, Jeff; Mody, Samir H. Journal: Journal of medical economics Issue: Volume 17:Number 10(2014) Page Start: 691 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Characteristics, management, and blood pressure control in patients with apparent resistant hypertension in the US. Issue 2 (February 2023) Authors: Ammann, Eric M.; O'Brien, Ellen S.; Milentijevic, Dejan; Kharat, Akshay A.; Talbot, Darren A.; Canovatchel, William; Haskell, Lloyd; Andrawis, Nabil S. Journal: Heliyon Issue: Volume 9:Issue 2(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗